The document discusses the company's quarterly earnings report. It notes that revenue was up 10% compared to the same period last year, driven by strong performance in the technology and healthcare sectors. However, net income was down slightly due to increased spending on research and development. The company reiterated its full-year guidance.
The document discusses the company's quarterly earnings report. It notes that revenue was up 10% compared to the same period last year, driven by strong performance in the technology and healthcare sectors. However, net income was down slightly due to increased spending on research and development. The company reiterated its full-year guidance.
The document discusses the company's quarterly earnings report. It notes that revenue was up 10% compared to the same period last year, driven by strong performance in the technology and healthcare sectors. However, net income was down slightly due to increased spending on research and development. The company reiterated its full-year guidance.
The document discusses the company's quarterly earnings report. It notes that revenue was up 10% compared to the same period last year, driven by strong performance in the technology and healthcare sectors. However, net income was down slightly due to increased spending on research and development. The company reiterated its full-year guidance.